DoW Autism Clinical Trial Award
Funds a clinical trial of a new autism treatment, product or device, from a small proof-of-concept study up to a full efficacy trial.
An autism intervention that looks promising in the lab still has to prove itself in people, and that's what this award pays for — not the earlier science, the trial.
Almost anything can be the thing under test: a new product, a drug or biologic, a device, clinical guidance, or an emerging approach or technology. Scale is flexible too, from a small proof-of-concept study — a pilot, a first-in-huma…
Clinical trials of new autism products, pharmacologic agents, devices, clinical guidance or emerging approaches and technologies, ranging from small proof-of-concept studies to large-scale efficacy trials, with a required named community partner providing ongoing advice and consultation throughout planning and implementation. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up